Renaissance Technologies’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,145,996
| Closed | -$481K | – | 3868 |
|
|
2018
Q4 | $481K | Buy |
1,145,996
+77,100
| +7% | +$47.9K | ﹤0.01% | 2874 |
|
|
2018
Q3 | $1.03M | Buy |
1,068,896
+115,146
| +12% | +$193K | ﹤0.01% | 2592 |
|
|
2018
Q2 | $2.32M | Buy |
953,750
+12,500
| +1% | +$30.6K | ﹤0.01% | 2191 |
|
|
2018
Q1 | $2.25M | Buy |
941,250
+26,500
| +3% | +$66.9K | ﹤0.01% | 2265 |
|
|
2017
Q4 | $2.19M | Buy |
914,750
+95,800
| +12% | +$265K | ﹤0.01% | 2289 |
|
|
2017
Q3 | $2.58M | Buy |
818,950
+18,900
| +2% | +$60.6K | ﹤0.01% | 2160 |
|
|
2017
Q2 | $3.22M | Buy |
800,050
+59,400
| +8% | +$259K | ﹤0.01% | 1989 |
|
|
2017
Q1 | $2.74M | Buy |
740,650
+47,700
| +7% | +$150K | ﹤0.01% | 2065 |
|
|
2016
Q4 | $1.34M | Buy |
692,950
+208,631
| +43% | +$755K | ﹤0.01% | 2414 |
|
|
2016
Q3 | $3.01M | Buy |
484,319
+262,879
| +119% | +$1.62M | 0.01% | 1947 |
|
|
2016
Q2 | $992K | Buy |
221,440
+208,246
| +1,578% | +$1.36M | ﹤0.01% | 2543 |
|
|
2016
Q1 | $139K | Sell |
13,194
-71,588
| -84% | -$1.42M | ﹤0.01% | 3162 |
|
|
2015
Q4 | $2.5M | Buy |
84,782
+38,422
| +83% | +$1.16M | 0.01% | 1970 |
|
|
2015
Q3 | $1.47M | Buy |
46,360
+40,658
| +713% | +$1.95M | ﹤0.01% | 2179 |
|
|
2015
Q2 | $338K | Buy |
+5,702
| New | +$402K | ﹤0.01% | 2839 |
|
|
2014
Q4 | – | Sell |
-10,084
| Closed | -$774K | – | 3251 |
|
|
2014
Q3 | $774K | Sell |
10,084
-5,680
| -36% | -$447K | ﹤0.01% | 2149 |
|
|
2014
Q2 | $1.42M | Buy |
+15,764
| New | +$966K | ﹤0.01% | 1899 |
|
Renaissance Technologies's PTX Position: Q1 2019 in Review
Renaissance Technologies sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 1,145,996 shares — an estimated $481K sold.
Renaissance Technologies first reported a position in PTX in Q2 2014 and held it in 17 quarters. The position peaked at $3.22M in Q2 2017. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Renaissance Technologies reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Renaissance Technologies sold 1,145,996 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $481K.
- Renaissance Technologies first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 17 quarters.
- Renaissance Technologies's Pernix Therapeutics Holdings, Inc. position peaked at $3.22M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.